CARLISLE COMPANIES INCORPORATED (CSL) capitalization

Current snapshot

Market Cap
$13.50B
40.5M shares × $333.62 · as of last filing 2026-03-31
Net Worth
$1.65B
Stockholders' equity · 2026-03-31
Enterprise Value
$15.62B
Market cap + debt − cash
Net Debt
$2.12B
Debt $2.89B − Cash $771.3M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $13.82B
FY'24 2024-12-31 $17.37B
FY'23 2023-12-31 $15.75B
FY'22 2022-12-31 $12.37B
FY'21 2021-12-31 $13.20B
FY'20 2020-12-31 $8.59B
FY'19 2019-12-31 $9.31B
FY'18 2018-12-31 $6.11B
FY'17 2017-12-31 $7.22B
FY'16 2016-12-31 $7.16B
FY'15 2015-12-31 $5.84B
FY'14 2014-12-31 $5.89B
FY'13 2013-12-31 $5.15B
FY'12 2012-12-31 $3.74B
FY'11 2011-12-31 $2.77B
FY'10 2010-12-31 $2.45B
FY'10 2009-12-31 $2.10B
FY'10 2008-12-31

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $13.71B
Q4'25 2025-12-31 $13.11B
Q3'25 2025-09-30 $14.11B
Q2'25 2025-06-30 $16.21B
Q1'25 2025-03-31 $15.22B
Q4'24 2024-12-31 $16.38B
Q3'24 2024-09-30 $20.91B
Q2'24 2024-06-30 $19.41B
Q1'24 2024-03-31 $18.97B
Q4'23 2023-12-31 $14.90B
Q3'23 2023-09-30 $12.99B
Q2'23 2023-06-30 $13.13B
Q1'23 2023-03-31 $11.69B
Q4'22 2022-12-31 $11.99B
Q3'22 2022-09-30 $14.75B
Q2'22 2022-06-30 $12.53B
Q1'22 2022-03-31 $13.01B
Q4'21 2021-12-31 $12.90B
Q3'21 2021-09-30 $10.54B
Q2'21 2021-06-30 $10.14B
Q1'21 2021-03-31 $8.82B
Q4'20 2020-12-31 $8.26B
Q3'20 2020-09-30 $6.67B
Q2'20 2020-06-30 $6.61B
Q1'20 2020-03-31 $7.08B
Q4'19 2019-12-31 $9.01B
Q3'19 2019-09-30 $8.34B
Q2'19 2019-06-30 $8.09B
Q1'19 2019-03-31 $7.10B
Q4'18 2018-12-31 $5.83B
Q3'18 2018-09-30 $7.35B
Q2'18 2018-06-30 $6.61B
Q1'18 2018-03-31 $6.49B
Q4'17 2017-12-31 $7.03B
Q3'17 2017-09-30 $6.30B
Q2'17 2017-06-30 $6.12B
Q1'17 2017-03-31 $6.90B
Q4'16 2016-12-31 $7.09B
Q3'16 2016-09-30 $6.60B
Q2'16 2016-06-30 $6.88B
Q1'16 2016-03-31 $6.46B
Q4'15 2015-12-31 $5.68B
Q3'15 2015-09-30 $5.77B
Q2'15 2015-06-30 $6.61B
Q1'15 2015-03-31 $6.10B
Q4'14 2014-12-31 $5.84B
Q3'14 2014-09-30 $5.26B
Q2'14 2014-06-30 $5.67B
Q1'14 2014-03-31 $5.16B
Q4'13 2013-12-31 $5.05B
Q3'13 2013-09-30 $4.56B
Q2'13 2013-06-30 $4.03B
Q1'13 2013-03-31 $4.39B
Q4'12 2012-12-31 $3.71B
Q3'12 2012-09-30 $3.32B
Q2'12 2012-06-30 $3.38B
Q1'12 2012-03-31 $3.16B
Q4'11 2011-12-31 $2.73B
Q3'11 2011-09-30 $1.99B
Q2'11 2011-06-30 $3.09B
Q1'11 2011-03-31 $2.77B
Q4'10 2010-12-31 $2.43B
Q3'10 2010-09-30 $1.84B
Q2'10 2010-06-30 $2.23B
Q1'11 2010-03-31
Q4'10 2009-12-31 $2.08B
Q3'10 2009-09-30
Q2'10 2009-06-30

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (CSL CIK 0000790051), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

NHTC

Natural Health Trends Corp.

VTGN

Vistagen Therapeutics, Inc.

DX

DYNEX CAPITAL, INC.